Edgewise Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2019 | — | — | $23.7M |
| Mar 2020 | — | — | $20.9M |
| Jun 2020 | — | — | $16.9M |
| Sep 2020 | — | — | $38.7M |
| Dec 2020 | $4.3M | $131.1M | $104.9M |
| Mar 2021 | $4.9M | $311.2M | $221.0M |
| Jun 2021 | $6.7M | $303.5M | $50.4M |
| Sep 2021 | $9.0M | $294.4M | $10.6M |
| Dec 2021 | $10.9M | $285.2M | $15.6M |
| Mar 2022 | $12.4M | $272.7M | $34.5M |
| Jun 2022 | $11.0M | $257.4M | $18.3M |
| Sep 2022 | $15.7M | $377.2M | $109.7M |
| Dec 2022 | $20.4M | $367.1M | $22.0M |
| Mar 2023 | $17.6M | $346.4M | $48.2M |
| Jun 2023 | $19.2M | $330.6M | $31.8M |
| Sep 2023 | $20.9M | $311.4M | $33.0M |
| Dec 2023 | $21.2M | $340.0M | $86.1M |
| Mar 2024 | $18.9M | $553.8M | $30.3M |
| Jun 2024 | $21.2M | $531.6M | $43.5M |
| Sep 2024 | $22.4M | $511.3M | $44.8M |
| Dec 2024 | $27.6M | $486.8M | $41.7M |
| Mar 2025 | $24.7M | $454.4M | $49.9M |
| Jun 2025 | $24.3M | $613.3M | $43.4M |
| Sep 2025 | $24.8M | $583.5M | $46.0M |
| Dec 2025 | $30.3M | $552.6M | $61.1M |
| Mar 2026 | $25.3M | $518.5M | $33.2M |
| Jun 2026 | $31.6M | $479.7M | $72.3M |